ALLO — Allogene Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapMomentum Trap

Annual balance sheet for Allogene Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	R2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	457	517	449	292	250
Net Total Receivables	1.9	1.8	1.7	1.9	1.5
Prepaid Expenses
Total Current Assets	471	529	459	303	258
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	181	196	163	131	113
Long Term Investments
Other Long Term Assets
Total Assets	1,039	822	643	549	416
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	48.2	53.7	37.1	35.5	32.5
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	122	155	131	127	123
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	916	667	512	422	293
Total Liabilities & Shareholders' Equity	1,039	822	643	549	416
Total Common Shares Outstanding